Stocktoria
Aurinia Pharmaceuticals Inc. AUPH
Aurinia Pharmaceuticals Inc. statistics & valuation
Market cap$2.2B
P / E7.7×
P / S7.8×
P / B3.8×
Net margin101.5%
Return on equity49.4%
Return on capital15.9%
Graham number -9.6%$13.97
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports. The Graham number is Benjamin Graham's rough maximum fair value ($13.97); a green figure means the price is below it.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating margin | 37.1% | -2.0% | -52.2% | -83.2% | -396.3% | -208.1% | -28598.4% |
| Net margin | 101.5% | 2.4% | -44.5% | -80.7% | -396.8% | -204.9% | -27794.0% |
| Return on assets | 38.2% | 1.0% | -14.2% | -23.0% | -33.3% | -22.1% | -27.3% |
| Return on equity | 49.4% | 1.5% | -20.6% | -26.7% | -37.8% | -25.2% | -29.6% |
| Current ratio | 5.25 | 4.57 | 5.50 | 9.60 | 12.63 | 13.11 | 27.90 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.